Publikasi Scopus 2023 per tanggal 30 Maret 2023 (184 artikel)

Supriadi I.R., Haanappel C.P., Saptawati L., Widodo N.H., Sitohang G., Usman Y., Anom I.B., Saraswati R.D., Heger M., Doevendans P.A., Satari H.I., Voor in ‘t holt A.F., Severin J.A.
58089138700;57216527345;57211348856;58089080400;57205655366;57207313665;58089160900;58089201500;55213971500;7004918581;57191347814;57202387807;8700385500;
Infection prevention and control in Indonesian hospitals: identification of strengths, gaps, and challenges
2023
Antimicrobial Resistance and Infection Control
12
1
6
Center for Health Policy on Resilience System and Resource, Health Policy Agency, Ministry of Health of Indonesia, Percetakan Negara 23, Jakarta, Indonesia; Department of Cardiology, University Medical Centre Utrecht, Utrecht, Netherlands; Department of Medical Microbiology and Infectious Diseases, Erasmus MC University Medical Centre, Rotterdam, Netherlands; Department of Microbiology, Faculty of Medicine, Universitas Sebelas Maret, Surakarta, Indonesia; Department of Microbiology, Moewardi Teaching Hospital, Surakarta, Indonesia; Directorate of Referral Health Care, Ministry of Health of Indonesia, Jakarta, Indonesia; Infection Prevention and Control Committee, Dr. Cipto Mangunkusumo General Hospital, Jakarta, Indonesia; Center for Health Financing and Decentralization Policy, Health Policy Agency, Ministry of Health of Indonesia, Jakarta, Indonesia; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands; Membrane Biochemistry and Biophysics, Department of Chemistry, Faculty of Science, Utrecht University, Utrecht, Netherlands; Laboratory for Experimental Oncology, Department of Pathology, Erasmus MC University Medical Centre, Rotterdam, Netherlands; Jiaxing Key Laboratory for Photonanomedicine and Experimental Therapeutics, Department of Pharmaceutics, College of Medicine, Jiaxing University, Zhejiang, Jiaxing, China; Department of Child Health, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia
Supriadi, I.R., Center for Health Policy on Resilience System and Resource, Health Policy Agency, Ministry of Health of Indonesia, Percetakan Negara 23, Jakarta, Indonesia, Department of Cardiology, University Medical Centre Utrecht, Utrecht, Netherlands, Department of Medical Microbiology and Infectious Diseases, Erasmus MC University Medical Centre, Rotterdam, Netherlands; Haanappel, C.P., Department of Medical Microbiology and Infectious Diseases, Erasmus MC University Medical Centre, Rotterdam, Netherlands; Saptawati, L., Department of Microbiology, Faculty of Medicine, Universitas Sebelas Maret, Surakarta, Indonesia, Department of Microbiology, Moewardi Teaching Hospital, Surakarta, Indonesia; Widodo, N.H., Directorate of Referral Health Care, Ministry of Health of Indonesia, Jakarta, Indonesia; Sitohang, G., Infection Prevention and Control Committee, Dr. Cipto Mangunkusumo General Hospital, Jakarta, Indonesia; Usman, Y., Center for Health Financing and Decentralization Policy, Health Policy Agency, Ministry of Health of Indonesia, Jakarta, Indonesia; Anom, I.B., Directorate of Referral Health Care, Ministry of Health of Indonesia, Jakarta, Indonesia; Saraswati, R.D., Center for Health Policy on Resilience System and Resource, Health Policy Agency, Ministry of Health of Indonesia, Percetakan Negara 23, Jakarta, Indonesia; Heger, M., Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands, Membrane Biochemistry and Biophysics, Department of Chemistry, Faculty of Science, Utrecht University, Utrecht, Netherlands, Laboratory for Experimental Oncology, Department of Pathology, Erasmus MC University Medical Centre, Rotterdam, Netherlands, Jiaxing Key Laboratory for Photonanomedicine and Experimental Therapeutics, Department of Pharmaceutics, College of Medicine, Jiaxing University, Zhejiang, Jiaxing, China; Doevendans, P.A., Department of Cardiology, University Medical Centre Utrecht, Utrecht, Netherlands; Satari, H.I., Infection Prevention and Control Committee, Dr. Cipto Mangunkusumo General Hospital, Jakarta, Indonesia, Department of Child Health, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Voor in ‘t holt, A.F., Department of Medical Microbiology and Infectious Diseases, Erasmus MC University Medical Centre, Rotterdam, Netherlands; Severin, J.A., Department of Medical Microbiology and Infectious Diseases, Erasmus MC University Medical Centre, Rotterdam, Netherlands
Background: Infection prevention and control (IPC) in hospitals is key to safe patient care. There is currently no data regarding the implementation of IPC in hospitals in Indonesia. The aim of this study was to assess the existing IPC level in a nationwide survey, using the World Health Organization (WHO) IPC assessment framework tool (IPCAF), and to identify strengths, gaps, and challenges. Methods: A cross-sectional study was conducted from July to November 2021. Of all general hospitals in Indonesia, 20% (N = 475) were selected using stratified random sampling based on class (A, B, C and D; class D with a maximum of 50 beds and class A with ≥ 250 beds) and region. The IPCAF was translated into Indonesian and tested in four hospitals. Questions were added regarding challenges in the implementation of IPC. Quantitative IPCAF scores are reported as median (minimum–maximum). IPC levels were calculated according to WHO tools. Results: In total, 355 hospitals (74.7%) participated in this study. The overall median IPCAF score was 620.0 (535.0–687.5). The level of IPC was mostly assessed as advanced (56.9% of hospitals), followed by intermediate (35.8%), basic (7.0%) and inadequate (0.3%). In the eastern region of the country, the majority of hospitals scored intermediate level. Of the eight core components, the one with the highest score was IPC guidelines. Almost all hospitals had guidelines on the most important topics, including hand hygiene. Core components with the lowest score were surveillance of healthcare-associated infections (HAIs), education and training, and multimodal strategies. Although > 90% of hospitals indicated that surveillance of HAIs was performed, 57.2% reported no availability of adequate microbiology laboratory capacity to support HAIs surveillance. The most frequently reported challenges in the implementation of IPC were communication with the management of the hospitals, followed by the unavailability of antimicrobial susceptibility testing results and insufficient staffing of full-time IPC nurses. Conclusion: The IPC level in the majority of Indonesian hospitals was assessed as advanced, but there was no even distribution over the country. The IPCAF in combination with interviews identified several priority areas for interventions to improve IPC in Indonesian hospitals. © 2023, The Author(s).
Healthcare-associated infections; Microbiology; Patient safety; Survey; World Health Organization
antibiotic sensitivity; Article; cross-sectional study; disease surveillance; general hospital; hand washing; health care policy; health education; health survey; healthcare associated infection; human; Indonesia; infection control; infection prevention; microbiology; patient safety; practice guideline; scoring system; World Health Organization; cross infection; hospital; procedures; Cross Infection; Cross-Sectional Studies; Hospitals; Humans; Indonesia; Infection Control
World Health Organization, WHO; Lembaga Pengelola Dana Pendidikan, LPDP
This project was supported by The Indonesian Endowment Fund for Education. The funder had no role on the design of the study, in data collection, analysis, interpretation, or writing and approval of the manuscript.
We thank the Indonesian Endowment Fund for Education (LPDP) for the funding. We acknowledge the input and support from the Ministry of Health of Indonesia and WHO representatives for Indonesia. We would like to sincerely thank all hospitals and IPC commit
BioMed Central Ltd
20472994
36732802
Article
Q1
1286
2738